Therapeutic leukapheresis in hyperleukocytic leukaemias - The experience of a tertiary institution in Singapore

Annals of the Academy of Medicine Singapore

Volumn 34, Issue 3, 2005, Pages 229-234

  Tan, Daryl ^a   Hwang, W ^a   Goh, Y T ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Apheresis; Cytoreduction; Hyperleukocytosis; Leukocytoreduction

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSTITUTIONAL CARE; LEUKAPHERESIS; LEUKEMIA; LEUKOCYTE; LEUKOCYTOSIS; LONG TERM CARE; MALE; MORTALITY; PROGNOSIS; SINGAPORE; LEUKOSTASIS; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LEUKAPHERESIS; LEUKEMIA; LEUKOCYTOSIS; LEUKOSTASIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SINGAPORE; TREATMENT OUTCOME;

EID: 22144448931     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Porcu P, Cripe L, Ng EW, Bhatia S, Danielson CM, Orazi A, et al. Hyperleukocytic leukaemia and leukostasis: A review of pathophysiology, clinical presentation and management. Leuk Lymphoma 2000;39:1-18.
2. McKee LC Jr, Colins RD. Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukaemia. Medicine 1974;53: 463-78.
3. Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 1987;9:1364-72.
4. Bloom R, Taveira DaSilva AM, Bracey A. Reversible respiratory failure due to intravascular leukostasis in chronic myelogenous leukemia. Relationship of oxygen transfer to leukocyte count. Am J Med 1979;67:679-83.
5. Eisenstaedt RS, Beckman EM. Rapid cytoreduction in acute leukaemia. Management of cerebral leukostasis by cell pheresis. Transfusion 1978;18:113-5.
6. Karp DD, Beck JR, Cornell CJ Jr. Chronic granulocyte leukemia with respiratory distress. Efficacy of emergency leukapheresis. Arch Intern Med 1981;141:1353-4.
7. Lane TA. Continuous-flow leukapheresis for rapid cytoreduction in leukemia. Transfusion 1980;20:455-7.
8. Mehta AB, Goldman JM, Kohner E. Hyperleucocytic retinopathy in chronic granulocytic leukaemia: the role of intensive leucapheresis. Br J Haematol 1984;56:661-7.
9. McCarthy LJ, Danielson CF, Rothenberger SS. Indications for emergency apheresis procedures. Crit Rev Clin Lab Sci 1997;34:573-610.
10. Wiernik PH, Serpick AA. Factors affecting remission and survival in adult acute nonlymphocytic leukemia. Medicine 1970;49:505-13.
11. Hug V, Keating MJ, McCredie KB, Hester J, Brodey GP, Freireich EJ. Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count. Cancer 1983;52:773-9.
12. Vaughan WP, Kimball AW, Karp JE, Dragon LH, Burke PJ. Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts. Cancer Treat Rep 1981;65:1007-13.
13. Giles FJ, Shen Y, Kantarjian HM, Korbling MJ, O'Brien S, Anderlini P, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma 2001;42:67-73.
14. Porcu P, Danielson CF, Orazi A, Heerema N, Gabig TG, McCarthy LJ. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality. Br J Haemato 1997;98:433-6.
15. Estey E. Reducing mortality associated with immediate treatment complications of adult leukemias. Semin Hematol 2001;38:32-7.
16. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, et al. Report of the National Cancer Institute sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990;8:813-9.
17. Cuttner J, Conjalka MS, Reiley M, Goldberg J, Reisman A, Meyer RJ, et al. Association of monocytic leukemia in patients with extreme leukocytosis. Am J Med 1980;69:555-8.
18. Scott CS, Stark AN, Limbert HJ, Masters PS, Head C, Roberts BE. Diagnostic and prognostic factors in acute monocytic leukaemia: an analysis of 51 cases. Br J Haematol 1988;69:247-52.
19. Kaneko Y, Maseki N, Takasaki N, Sakurai M, Hayashi Y, Nakazawa S, et al. Clinical and hematologic characteristics in acute leukemia with 11q23 translocations. Blood 1986;67:484-91.
20. Archimbaud E, Charrin C, Magaud JP, Campos L, Thomas X, Fiere D, et al. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint. Leukemia 1998;12:25-33.
21. Lightman MA. Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. Possible relationship to clinical manifestations. J Clin Invest 1973;52:350-8.
22. van Buchem MA, Hogendoorn PC, Levelt CN, van Hengel P, Colly LP, Kluin PM, et al. Development of pulmonary leukostasis in experimental myelocytic leukaemia in the Brown-Norway rat. Leukaemia 1992;6: 142-9.
23. Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 2001;97:2121-9.
24. Doerschuk CM, Quinlan WM, Doyle NA, Bullard DC, Vestweber D, Jones ML, et al. The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J Immunol 1996;157:4609-14.
25. Kumasaka T, Quinlan WM, Doyle NA, Condon TP, Sligh J, Takei F, et al. Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest 1996;97:2362-9.
26. Hammond D, Sather H, Nesbit M, Coccia P, Bleyer A, Lukens J. Analysis of prognostic factors in acute lymphoblastic leukaemia. Med Paediatr Oncol 1989;14:158-63.
27. Hoelzer D, Thiel E, Loeffler H, Buchner T, Ganser A, Heil G, et al. Prognostic factors in a multicentre study for treatment of acute lymphoblastic leukemia in adults. Blood 1988;71:123-31.
28. Ablin AR. Managing the problem of hyperleukocytosis in acute leukemia. Am J Paediatr Hematol Oncol 1984;6:287-90.